Global Sickle Cell Disease Drug Market Research Report 2024

Report ID: 1978028 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Sickle Cell Disease Drug Market Overview
    1.1 Product Overview and Scope of Sickle Cell Disease Drug
    1.2 Sickle Cell Disease Drug Segment by Type
        1.2.1 Global Sickle Cell Disease Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 ARQ-092
        1.2.3 BIVV-003
        1.2.4 CAL-H
        1.2.5 CTX-001
        1.2.6 DRX-194
        1.2.7 Others
    1.3 Sickle Cell Disease Drug Segment by Application
        1.3.1 Global Sickle Cell Disease Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Sickle Cell Disease Drug Market Size Estimates and Forecasts
        1.4.1 Global Sickle Cell Disease Drug Revenue 2017-2028
        1.4.2 Global Sickle Cell Disease Drug Sales 2017-2028
        1.4.3 Sickle Cell Disease Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Sickle Cell Disease Drug Market Competition by Manufacturers
    2.1 Global Sickle Cell Disease Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Sickle Cell Disease Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Sickle Cell Disease Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Sickle Cell Disease Drug Manufacturing Sites, Area Served, Product Type
    2.5 Sickle Cell Disease Drug Market Competitive Situation and Trends
        2.5.1 Sickle Cell Disease Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Sickle Cell Disease Drug Players Market Share by Revenue
        2.5.3 Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sickle Cell Disease Drug Retrospective Market Scenario by Region
    3.1 Global Sickle Cell Disease Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Sickle Cell Disease Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Sickle Cell Disease Drug Market Facts & Figures by Country
        3.3.1 North America Sickle Cell Disease Drug Sales by Country
        3.3.2 North America Sickle Cell Disease Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Sickle Cell Disease Drug Market Facts & Figures by Country
        3.4.1 Europe Sickle Cell Disease Drug Sales by Country
        3.4.2 Europe Sickle Cell Disease Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Sickle Cell Disease Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Sickle Cell Disease Drug Sales by Region
        3.5.2 Asia Pacific Sickle Cell Disease Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Sickle Cell Disease Drug Market Facts & Figures by Country
        3.6.1 Latin America Sickle Cell Disease Drug Sales by Country
        3.6.2 Latin America Sickle Cell Disease Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Sickle Cell Disease Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Sickle Cell Disease Drug Sales by Country
        3.7.2 Middle East and Africa Sickle Cell Disease Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Sickle Cell Disease Drug Historic Market Analysis by Type
    4.1 Global Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)
    4.2 Global Sickle Cell Disease Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Sickle Cell Disease Drug Price by Type (2017-2022)
5 Global Sickle Cell Disease Drug Historic Market Analysis by Application
    5.1 Global Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)
    5.2 Global Sickle Cell Disease Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Sickle Cell Disease Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Acceleron Pharma Inc
        6.1.1 Acceleron Pharma Inc Corporation Information
        6.1.2 Acceleron Pharma Inc Description and Business Overview
        6.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Product Portfolio
        6.1.5 Acceleron Pharma Inc Recent Developments/Updates
    6.2 Addmedica SAS
        6.2.1 Addmedica SAS Corporation Information
        6.2.2 Addmedica SAS Description and Business Overview
        6.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Addmedica SAS Sickle Cell Disease Drug Product Portfolio
        6.2.5 Addmedica SAS Recent Developments/Updates
    6.3 Angiocrine Bioscience Inc
        6.3.1 Angiocrine Bioscience Inc Corporation Information
        6.3.2 Angiocrine Bioscience Inc Description and Business Overview
        6.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Portfolio
        6.3.5 Angiocrine Bioscience Inc Recent Developments/Updates
    6.4 Annexin Pharmaceuticals AB
        6.4.1 Annexin Pharmaceuticals AB Corporation Information
        6.4.2 Annexin Pharmaceuticals AB Description and Business Overview
        6.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Portfolio
        6.4.5 Annexin Pharmaceuticals AB Recent Developments/Updates
    6.5 ArQule Inc
        6.5.1 ArQule Inc Corporation Information
        6.5.2 ArQule Inc Description and Business Overview
        6.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 ArQule Inc Sickle Cell Disease Drug Product Portfolio
        6.5.5 ArQule Inc Recent Developments/Updates
    6.6 Bio Products Laboratory Ltd
        6.6.1 Bio Products Laboratory Ltd Corporation Information
        6.6.2 Bio Products Laboratory Ltd Description and Business Overview
        6.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Portfolio
        6.6.5 Bio Products Laboratory Ltd Recent Developments/Updates
    6.7 Bioverativ Inc
        6.6.1 Bioverativ Inc Corporation Information
        6.6.2 Bioverativ Inc Description and Business Overview
        6.6.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bioverativ Inc Sickle Cell Disease Drug Product Portfolio
        6.7.5 Bioverativ Inc Recent Developments/Updates
    6.8 bluebird bio Inc
        6.8.1 bluebird bio Inc Corporation Information
        6.8.2 bluebird bio Inc Description and Business Overview
        6.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 bluebird bio Inc Sickle Cell Disease Drug Product Portfolio
        6.8.5 bluebird bio Inc Recent Developments/Updates
    6.9 Bristol-Myers Squibb Co
        6.9.1 Bristol-Myers Squibb Co Corporation Information
        6.9.2 Bristol-Myers Squibb Co Description and Business Overview
        6.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Portfolio
        6.9.5 Bristol-Myers Squibb Co Recent Developments/Updates
    6.10 Calimmune Inc
        6.10.1 Calimmune Inc Corporation Information
        6.10.2 Calimmune Inc Description and Business Overview
        6.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Calimmune Inc Sickle Cell Disease Drug Product Portfolio
        6.10.5 Calimmune Inc Recent Developments/Updates
    6.11 CRISPR Therapeutics
        6.11.1 CRISPR Therapeutics Corporation Information
        6.11.2 CRISPR Therapeutics Sickle Cell Disease Drug Description and Business Overview
        6.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Product Portfolio
        6.11.5 CRISPR Therapeutics Recent Developments/Updates
    6.12 CSL Ltd
        6.12.1 CSL Ltd Corporation Information
        6.12.2 CSL Ltd Sickle Cell Disease Drug Description and Business Overview
        6.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 CSL Ltd Sickle Cell Disease Drug Product Portfolio
        6.12.5 CSL Ltd Recent Developments/Updates
    6.13 Daiichi Sankyo Co Ltd
        6.13.1 Daiichi Sankyo Co Ltd Corporation Information
        6.13.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Description and Business Overview
        6.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Portfolio
        6.13.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
    6.14 Editas Medicine Inc
        6.14.1 Editas Medicine Inc Corporation Information
        6.14.2 Editas Medicine Inc Sickle Cell Disease Drug Description and Business Overview
        6.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Editas Medicine Inc Sickle Cell Disease Drug Product Portfolio
        6.14.5 Editas Medicine Inc Recent Developments/Updates
    6.15 Errant Gene Therapeutics LLC
        6.15.1 Errant Gene Therapeutics LLC Corporation Information
        6.15.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Description and Business Overview
        6.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Portfolio
        6.15.5 Errant Gene Therapeutics LLC Recent Developments/Updates
    6.16 Gamida Cell Ltd
        6.16.1 Gamida Cell Ltd Corporation Information
        6.16.2 Gamida Cell Ltd Sickle Cell Disease Drug Description and Business Overview
        6.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Product Portfolio
        6.16.5 Gamida Cell Ltd Recent Developments/Updates
    6.17 Genethon SA
        6.17.1 Genethon SA Corporation Information
        6.17.2 Genethon SA Sickle Cell Disease Drug Description and Business Overview
        6.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Genethon SA Sickle Cell Disease Drug Product Portfolio
        6.17.5 Genethon SA Recent Developments/Updates
    6.18 Gilead Sciences Inc
        6.18.1 Gilead Sciences Inc Corporation Information
        6.18.2 Gilead Sciences Inc Sickle Cell Disease Drug Description and Business Overview
        6.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Product Portfolio
        6.18.5 Gilead Sciences Inc Recent Developments/Updates
    6.19 Global Blood Therapeutics Inc
        6.19.1 Global Blood Therapeutics Inc Corporation Information
        6.19.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Description and Business Overview
        6.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Portfolio
        6.19.5 Global Blood Therapeutics Inc Recent Developments/Updates
7 Sickle Cell Disease Drug Manufacturing Cost Analysis
    7.1 Sickle Cell Disease Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
    7.4 Sickle Cell Disease Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Sickle Cell Disease Drug Distributors List
    8.3 Sickle Cell Disease Drug Customers
9 Sickle Cell Disease Drug Market Dynamics
    9.1 Sickle Cell Disease Drug Industry Trends
    9.2 Sickle Cell Disease Drug Market Drivers
    9.3 Sickle Cell Disease Drug Market Challenges
    9.4 Sickle Cell Disease Drug Market Restraints
10 Global Market Forecast
    10.1 Sickle Cell Disease Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Sickle Cell Disease Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Type (2023-2028)
    10.2 Sickle Cell Disease Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Sickle Cell Disease Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Application (2023-2028)
    10.3 Sickle Cell Disease Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Sickle Cell Disease Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Sickle Cell Disease Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Sickle Cell Disease Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Sickle Cell Disease Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Sickle Cell Disease Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Sickle Cell Disease Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Sickle Cell Disease Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Sickle Cell Disease Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Sickle Cell Disease Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Sickle Cell Disease Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Sickle Cell Disease Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Sickle Cell Disease Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Sickle Cell Disease Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Sickle Cell Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Sickle Cell Disease Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Sickle Cell Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Sickle Cell Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Sickle Cell Disease Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Sickle Cell Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Sickle Cell Disease Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Sickle Cell Disease Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Sickle Cell Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Sickle Cell Disease Drug Revenue Share by Type (2017-2022)
    Table 43. Global Sickle Cell Disease Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Sickle Cell Disease Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Sickle Cell Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Sickle Cell Disease Drug Revenue Share by Application (2017-2022)
    Table 48. Global Sickle Cell Disease Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Acceleron Pharma Inc Corporation Information
    Table 50. Acceleron Pharma Inc Description and Business Overview
    Table 51. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Acceleron Pharma Inc Sickle Cell Disease Drug Product
    Table 53. Acceleron Pharma Inc Recent Developments/Updates
    Table 54. Addmedica SAS Corporation Information
    Table 55. Addmedica SAS Description and Business Overview
    Table 56. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Addmedica SAS Sickle Cell Disease Drug Product
    Table 58. Addmedica SAS Recent Developments/Updates
    Table 59. Angiocrine Bioscience Inc Corporation Information
    Table 60. Angiocrine Bioscience Inc Description and Business Overview
    Table 61. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product
    Table 63. Angiocrine Bioscience Inc Recent Developments/Updates
    Table 64. Annexin Pharmaceuticals AB Corporation Information
    Table 65. Annexin Pharmaceuticals AB Description and Business Overview
    Table 66. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product
    Table 68. Annexin Pharmaceuticals AB Recent Developments/Updates
    Table 69. ArQule Inc Corporation Information
    Table 70. ArQule Inc Description and Business Overview
    Table 71. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. ArQule Inc Sickle Cell Disease Drug Product
    Table 73. ArQule Inc Recent Developments/Updates
    Table 74. Bio Products Laboratory Ltd Corporation Information
    Table 75. Bio Products Laboratory Ltd Description and Business Overview
    Table 76. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product
    Table 78. Bio Products Laboratory Ltd Recent Developments/Updates
    Table 79. Bioverativ Inc Corporation Information
    Table 80. Bioverativ Inc Description and Business Overview
    Table 81. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Bioverativ Inc Sickle Cell Disease Drug Product
    Table 83. Bioverativ Inc Recent Developments/Updates
    Table 84. bluebird bio Inc Corporation Information
    Table 85. bluebird bio Inc Description and Business Overview
    Table 86. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. bluebird bio Inc Sickle Cell Disease Drug Product
    Table 88. bluebird bio Inc Recent Developments/Updates
    Table 89. Bristol-Myers Squibb Co Corporation Information
    Table 90. Bristol-Myers Squibb Co Description and Business Overview
    Table 91. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product
    Table 93. Bristol-Myers Squibb Co Recent Developments/Updates
    Table 94. Calimmune Inc Corporation Information
    Table 95. Calimmune Inc Description and Business Overview
    Table 96. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Calimmune Inc Sickle Cell Disease Drug Product
    Table 98. Calimmune Inc Recent Developments/Updates
    Table 99. CRISPR Therapeutics Corporation Information
    Table 100. CRISPR Therapeutics Description and Business Overview
    Table 101. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. CRISPR Therapeutics Sickle Cell Disease Drug Product
    Table 103. CRISPR Therapeutics Recent Developments/Updates
    Table 104. CSL Ltd Corporation Information
    Table 105. CSL Ltd Description and Business Overview
    Table 106. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. CSL Ltd Sickle Cell Disease Drug Product
    Table 108. CSL Ltd Recent Developments/Updates
    Table 109. Daiichi Sankyo Co Ltd Corporation Information
    Table 110. Daiichi Sankyo Co Ltd Description and Business Overview
    Table 111. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product
    Table 113. Daiichi Sankyo Co Ltd Recent Developments/Updates
    Table 114. Editas Medicine Inc Corporation Information
    Table 115. Editas Medicine Inc Description and Business Overview
    Table 116. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. Editas Medicine Inc Sickle Cell Disease Drug Product
    Table 118. Editas Medicine Inc Recent Developments/Updates
    Table 119. Errant Gene Therapeutics LLC Corporation Information
    Table 120. Errant Gene Therapeutics LLC Description and Business Overview
    Table 121. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product
    Table 123. Errant Gene Therapeutics LLC Recent Developments/Updates
    Table 124. Gamida Cell Ltd Corporation Information
    Table 125. Gamida Cell Ltd Description and Business Overview
    Table 126. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 127. Gamida Cell Ltd Sickle Cell Disease Drug Product
    Table 128. Gamida Cell Ltd Recent Developments/Updates
    Table 129. Genethon SA Corporation Information
    Table 130. Genethon SA Description and Business Overview
    Table 131. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 132. Genethon SA Sickle Cell Disease Drug Product
    Table 133. Genethon SA Recent Developments/Updates
    Table 134. Gilead Sciences Inc Corporation Information
    Table 135. Gilead Sciences Inc Description and Business Overview
    Table 136. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 137. Gilead Sciences Inc Sickle Cell Disease Drug Product
    Table 138. Gilead Sciences Inc Recent Developments/Updates
    Table 139. Global Blood Therapeutics Inc Corporation Information
    Table 140. Global Blood Therapeutics Inc Description and Business Overview
    Table 141. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 142. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product
    Table 143. Global Blood Therapeutics Inc Recent Developments/Updates
    Table 144. Production Base and Market Concentration Rate of Raw Material
    Table 145. Key Suppliers of Raw Materials
    Table 146. Sickle Cell Disease Drug Distributors List
    Table 147. Sickle Cell Disease Drug Customers List
    Table 148. Sickle Cell Disease Drug Market Trends
    Table 149. Sickle Cell Disease Drug Market Drivers
    Table 150. Sickle Cell Disease Drug Market Challenges
    Table 151. Sickle Cell Disease Drug Market Restraints
    Table 152. Global Sickle Cell Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 153. Global Sickle Cell Disease Drug Sales Market Share Forecast by Type (2023-2028)
    Table 154. Global Sickle Cell Disease Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 155. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 156. Global Sickle Cell Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 157. Global Sickle Cell Disease Drug Sales Market Share Forecast by Application (2023-2028)
    Table 158. Global Sickle Cell Disease Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 159. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 160. Global Sickle Cell Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 161. Global Sickle Cell Disease Drug Sales Market Share Forecast by Region (2023-2028)
    Table 162. Global Sickle Cell Disease Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 163. Global Sickle Cell Disease Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Sickle Cell Disease Drug
    Figure 2. Global Sickle Cell Disease Drug Market Share by Type in 2021 & 2028
    Figure 3. ARQ-092 Product Picture
    Figure 4. BIVV-003 Product Picture
    Figure 5. CAL-H Product Picture
    Figure 6. CTX-001 Product Picture
    Figure 7. DRX-194 Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Sickle Cell Disease Drug Market Share by Application in 2021 & 2028
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global Sickle Cell Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Sickle Cell Disease Drug Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Sickle Cell Disease Drug Sales (2017-2028) & (K Pcs)
    Figure 16. Sickle Cell Disease Drug Sales Share by Manufacturers in 2021
    Figure 17. Global Sickle Cell Disease Drug Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Sickle Cell Disease Drug Players: Market Share by Revenue in 2021
    Figure 19. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Sickle Cell Disease Drug Sales Market Share by Region (2017-2022)
    Figure 21. Global Sickle Cell Disease Drug Sales Market Share by Region in 2021
    Figure 22. Global Sickle Cell Disease Drug Revenue Market Share by Region (2017-2022)
    Figure 23. Global Sickle Cell Disease Drug Revenue Market Share by Region in 2021
    Figure 24. U.S. Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. UAE Sickle Cell Disease Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Sickle Cell Disease Drug by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Sickle Cell Disease Drug
    Figure 50. Manufacturing Process Analysis of Sickle Cell Disease Drug
    Figure 51. Sickle Cell Disease Drug Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc
Frequently Asked Questions
Sickle Cell Disease Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sickle Cell Disease Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sickle Cell Disease Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports